Norfloxacin

诺氟沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameNorfloxacin
Drug Alias Namenorfloxacino诺弗洒欣力醇罗norfloxacineNorfloxacinum +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCystitisProstatitisLiver Cirrhosis +[11] 
Global Approved IndicationsProstatitisUrinary Tract InfectionsGonorrhea +[6] 
Approved Indications in ChinaProstatitisUrinary Tract InfectionsGonorrhea +[5] 
Original Approved Country/TerritoryItaly
Original Approved Date1983/09/01
Country/TerritoryCanadaUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Holdings IncThe Central Pharmaceutical Co Ltd
Inactive CompaniesUniversity of TorontoTanta UniversityMerck & Co Inc +[5] 
Active IndicationsProstatitisUrinary Tract InfectionsGonorrhea +[6] 
Inactive IndicationsCystitisLiver CirrhosisHepatopulmonary Syndrome +[5] 

Other Information

ATC CodeJ01MA06S01AE02
Related LinksWikipediaDrugBankKEGG